PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Co-toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis
Choroszy, M.; Sobieszczańska, B.; Litwinowicz, K.; Łaczmański, Ł.; Chmielarz, M.; Walczuk, U.; Roleder, T.; Radziejewska, J.; Wawrzyńska, M. Co-Toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022, 14, 424, doi:10.3390/nu14030424.
Choroszy, M.; Sobieszczańska, B.; Litwinowicz, K.; Łaczmański, Ł.; Chmielarz, M.; Walczuk, U.; Roleder, T.; Radziejewska, J.; Wawrzyńska, M. Co-Toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022, 14, 424, doi:10.3390/nu14030424.
Choroszy, M.; Sobieszczańska, B.; Litwinowicz, K.; Łaczmański, Ł.; Chmielarz, M.; Walczuk, U.; Roleder, T.; Radziejewska, J.; Wawrzyńska, M. Co-Toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022, 14, 424, doi:10.3390/nu14030424.
Choroszy, M.; Sobieszczańska, B.; Litwinowicz, K.; Łaczmański, Ł.; Chmielarz, M.; Walczuk, U.; Roleder, T.; Radziejewska, J.; Wawrzyńska, M. Co-Toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022, 14, 424, doi:10.3390/nu14030424.
Abstract
Gut dysbiosis, alongside with high-fat diet and cigarette smoking, is considered one of the factors promoting coronary arterial disease (CAD) development. The present study aimed to research whether gut dysbiosis can increase bacterial metabolites concentration in the blood of CAD patients and what impact these metabolites can exert on endothelial cells. The gut microbiome of 15 CAD patients and age-matched 15 healthy controls was analyzed by metagenome sequencing. The in vitro impact of LPS and indoxyl sulfate at concentrations present in patients sera on endothelial cells was investigated. A metagenome sequencing analysis revealed gut dysbiosis in CAD patients, further confirmed by elevated levels of LPS and indoxyl sulfate in patients sera. CAD was associated with depletion of Bacteroidetes and Alistipes. LPS and indoxyl sulfate in meager concentrations demonstrated co-toxicity to endothelial cells inducing reactive oxygen species, E-selectin, and monocyte chemoattractant protein-1 (MCP-1) production and promoting thrombogenicity of endothelial cells confirmed by monocyte adherence. The co-toxicity of LPS and indoxyl sulfate was associated with harmful effects on endothelial cells, strongly suggesting that gut dysbiosis-associated increased intestinal permeability can initiate or promote endothelial inflammation and atherosclerosis progression.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.